Reid Huber Ph.D Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 6

  • Med. Deal Size

  • Med. Valuation

Reid Huber Ph.D General Information

Biography

Dr. Reid Huber serves as Partner at Third Rock Ventures. Mr. Huber serves as a Board Member at Rapport Therapeutics. He served as a Board Member at Cargo Therapeutics. He serves as a Board Member at Tango Therapeutics. He also serves as a Board Member at Bellicum Pharmaceuticals, Terremoto Biosciences, MoMa Therapeutics, Asher Biotherapeutics. He serves as a Board Observer at insitro. He serves as an Advisory Board Member at Mass General Brigham Innovation. He brings over 20 years of operating experience in the biotechnology industry to focus on the formation, development, and strategy of our portfolio companies. He was a member of the founding scientific team at Incyte in 2002 and most recently served as the company's Executive Vice President and Chief Scientific Officer. He serves as an Advisory Board Member at Partners HealthCare Innovation. He has held roles of increasing responsibility in both drug discovery and clinical development at Incyte, most recently as Executive Director of clinical Development. Prior to Incyte, he held positions of increasing responsibility at Dupont Pharmaceuticals and Bristol-Myers Squibb. He conducted his postdoctoral training at the National Institutes of Health. Dr. Huber held intramural pre-doctoral and post-doctoral fellowships at the National Institutes of Health from 1997-1998. He is particularly excited about initiatives at the firm that combine deep understandings of disease genetics, data science, and translational medicine. He is consistently impressed with his colleague's focus on leveraging emerging areas of high-potential science to create breakthrough medicines for patients. Dr. Huber received his B.S. in biochemistry/molecular genetics from Murray State University and his Ph.D. in molecular genetics from Washington University.

Contact Information

Primary Position
Education
Washington University in St. Louis, Ph.D. (Doctor of Philosophy)
Murray State University, BS (Bachelor of Science)
Gender
Male
Email
rh
Phone
+1 (617)
Address
  • 201 Brookline Avenue
  • Suite 1401
  • Boston, MA 02215
  • United States
+1 (617)

Reid Huber Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
Third Rock Ventures Investor Partner Boston, MA Venture Capital

Reid Huber Ph.D Board Seats (6)

Company Industry Ownership Status Financing Status Location Since
AsherBio Drug Discovery Privately Held (backing) Venture Capital-Backed South San Francisco, CA
Cargo Therapeutics Drug Discovery Publicly Held Formerly VC-backed San Carlos, CA
insitro Drug Discovery Privately Held (backing) Venture Capital-Backed South San Francisco, CA
MoMa Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, MA
Rapport Therapeutics Drug Discovery Publicly Held Formerly VC-backed Boston, MA

Reid Huber Ph.D Lead Partner on Deals (10)

Reid Huber Ph.D has been the lead partner on 10 deals. Their latest deal was with Synnovation Therapeutics, a drug discovery company. The deal was made for on 24-Jan-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Synnovation Therapeutics 24-Jan-2024 Early Stage VC (Series A) Completed Drug Discovery Wilmington, DE
Tango Therapeutics 11-Aug-2023 Completed Drug Discovery Boston, MA
Rapport Therapeutics 07-Aug-2023 Completed Drug Discovery Boston, MA
Rapport Therapeutics 07-Mar-2023 Completed Drug Discovery Boston, MA
Cargo Therapeutics 09-Feb-2023 Completed Drug Discovery San Carlos, CA
Terremoto Biosciences 25-May-2022 Completed Drug Delivery San Francisco, CA
MoMa Therapeutics 09-May-2022 Completed Drug Discovery Cambridge, MA
MoMa Therapeutics 15-Apr-2020 Completed Drug Discovery Cambridge, MA
Syros Pharmaceuticals 08-Jan-2018 PIPE Completed Drug Discovery Cambridge, MA
Calithera 31-Mar-2017 PIPE Completed Biotechnology South San Francisco, CA

Reid Huber Ph.D Network (187)

Board Members (66)

Name Company Representing Location From
Mace Rothenberg MD Tango Therapeutics Self Boston, MA
Abraham Ceesay Rapport Therapeutics Rapport Therapeutics Boston, MA
Bellicum Pharmaceuticals Self Houston, TX
AsherBio AsherBio South San Francisco, CA
insitro Self South San Francisco, CA

Portfolio Executives (105)

Name Company Role Deal date Location
Wenqing Yao Ph.D Synnovation Therapeutics Co-Founder, Chief Executive Officer & Board Member 24-Jan-2024 Wilmington, DE
Liangxing Wu Ph.D Synnovation Therapeutics Co-Founder, Senior Vice President of Drug Discovery & Board Member 24-Jan-2024 Wilmington, DE
Tango Therapeutics Co-Founder 11-Aug-2023 Boston, MA
Tango Therapeutics Chief Development Operations Office 11-Aug-2023 Boston, MA
Tango Therapeutics Executive 11-Aug-2023 Boston, MA

Fund Team Members (16)

Name Investor Fund Fund Location
Charles Homcy MD Third Rock Ventures Third Rock Ventures IV Boston, MA
Charles Homcy MD Third Rock Ventures Third Rock Ventures V Boston, MA
Third Rock Ventures Boston, MA
Third Rock Ventures Boston, MA
Third Rock Ventures Boston, MA

Reid Huber Ph.D Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Third Rock Ventures IV Third Rock Ventures Venture - General Closed 2016
Third Rock Ventures V Third Rock Ventures Venture - General Closed 2020

Reid Huber Ph.D Advisory Roles (1)

Firm name Firm type Title Location Industry Since
Mass General Brigham Innovation Investor Advisory Board Member Cambridge, MA Corporate Venture Capital

Reid Huber Ph.D FAQs

  • Who is Reid Huber Ph.D?

    Dr. Reid Huber serves as Partner at Third Rock Ventures.

  • How much does Reid Huber Ph.D typically invest?

    Reid Huber Ph.D's median deal size is .

  • What is Reid Huber Ph.D’s main position?

    Reid Huber Ph.D’s primary position is Partner.

  • What are the contact details for Reid Huber Ph.D?

    Reid Huber Ph.D’s email address is rh and his phone number is +1 (617) .

  • How many active board seats does Reid Huber Ph.D hold?

    Reid Huber Ph.D holds 6 board seats including AsherBio, Cargo Therapeutics, insitro, MoMa Therapeutics, and Rapport Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »